Advertisement
Screener

Nuvectis Pharma, Inc. (NVCT) Stock Split Ratio

2.8 / 5 stars · 68/120 Roast Me

Nuvectis Pharma, Inc. Stock Split Ratio

Nuvectis Pharma, Inc. (NVCT) reported Stock Split Ratio of 100.00% for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.

Discontinued › Notes › Stockholders' Equity Note

us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-03-08

  • Nuvectis Pharma, Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2022-03-31 was 100.00%.
Period endStockholders' Equity Note, Stock Split, Conversion RatioStockholders' Equity Note, Stock Split, Conversion Ratio as first filedStockholders' Equity Note, Stock Split, Conversion Ratio 1 monthStockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filedStockholders' Equity Note, Stock Split, Conversion Ratio 3 monthStockholders' Equity Note, Stock Split, Conversion Ratio 6 monthStockholders' Equity Note, Stock Split, Conversion Ratio 9 month
2022-09-30100.00%
10-Q · filed 2022-11-08
2022-06-30100.00%
10-Q · filed 2022-08-10
2022-03-31100.00%
10-Q · filed 2022-05-12
2021-10-232.56%
10-K · filed 2023-03-08
3900.00%
10-Q · filed 2022-05-12
2021-05-311.00%
10-K · filed 2023-03-08
10000.00%
10-Q · filed 2022-05-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Verastem, Inc. (VSTM)United States$0.706B-1.71
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56